BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:1511@azbio.org
DTSTART;TZID=America/Phoenix:20200914T173000
DTEND;TZID=America/Phoenix:20200914T183000
DTSTAMP:20200913T121055Z
URL:https://www.azbio.org/events/leading-women-2020
SUMMARY:Leading Women Bioscience and Beyond -  - 14 Sep 20 17:30
DESCRIPTION:\n\n&nbsp\;\nKick off AZBW 2020 in style and meet some of our c
 ommunity's thought leaders at this virtual happy hour hosted by Perkins Co
 ie Phoenix.\nJoin us for an inspirational conversation and the AZBW 2020 K
 ick Off\n\nSeptember 14\, 2020\n\nFrom 5:30 PM - 6:30 PM.\n\nThis is a fre
 e event that is available to signup for via your AZBW app after registrati
 on.\n\nRegister for this and other free Arizona Bioscience Week Educationa
 l Events via the AZBW 2020 App\nRegister for AZBW 2020\nMeet Our Leading W
 omen Panelists:\nLara Dueppen\,&nbsp\; Perkins Coie (Moderator)\n\nDr. Lar
 a Dueppen is a partner in the firm's Intellectual Property practice and is
  also the Hiring Partner for the Los Angeles office. She has experience in
  a wide range of intellectual property development and protection\, includ
 ing:\n\n 	Patent procurement and global patent portfolio management\n 	Str
 ategic counseling on matters including patentability\, due diligence\, and
  freedom-to-operate\n 	Inter partes&nbsp\;review proceedings before the Pa
 tent Trial and Appeal Board\n 	Patent litigation before the Federal courts
 \n\nLara has represented clients in matters covering a broad range of tech
 nologies\, primarily focused on biotechnology. Representative clients incl
 ude startup companies\, public and private research institutions and large
  pharmaceutical companies.\n\nTrained as an interdisciplinary physiologist
 \, Lara pursued undergraduate and graduate research projects related to en
 docrinology\, neuroendocrinology and cardiology. Her doctoral research foc
 used on estrogen's effect on the development and treatment of atherosclero
 sis and the physical and molecular changes to the arterial wall with vario
 us treatment courses.\n\nIn her legal practice\, Lara has advised clients 
 working in such technologies as antibody therapeutics\, cellular therapeut
 ics\, nucleic acid and small molecule therapeutics\, vaccines\,&nbsp\;in v
 ivo&nbsp\;and&nbsp\;in vitro diagnostics\, recombinant DNA and proteins\, 
 in silico computer modeling and algorithms of biological and pathological 
 processes\, and nanotechnology. (More)f Arizona.\nJoni Anderson\, VP\, Reg
 ulatory Affairs\, BD Peripheral Intervention\nBD Peripheral Intervention h
 as a long history of providing medical device innovations\, proven to be r
 eliable\, that are truly making a difference in patients’ lives. The BD 
 Peripheral Intervention business unit offers a comprehensive range of medi
 cal products\, devices and services for the treatment of peripheral arteri
 al and venous disease\, cancer detection\, and end-stage renal disease and
  maintenance.\n\n&nbsp\;\nJen Koevary\, Ph.D. – Chief Operating and Fina
 ncial Officer\, Avery Therapeutics\nDr. Koevary has a background in busine
 ss development and medical device R&amp\;D. She was previously responsible
  for commercialization of university technology at the University of Arizo
 na\, where she led educational programs\, community engagement programs fo
 r small business funding (including the U of A I-Corps Site program)\, bus
 iness development assistance and the university’s asset development prog
 ram\, with &gt\;70 projects under management. Dr. Koevary has previously h
 eld high responsibility roles in startup companies Yakaroni\, LLC and Surg
 ical Tools\, LLC\, and has prior research and consulting experience in des
 ign and analysis for medical devices/software. Dr. Koevary earned a B.S. i
 n Mechanical Engineering\, B.S. in Health Sciences\, &nbsp\;and a Ph.D. in
  Biomedical Engineering with a minor in Entrepreneurship from the Universi
 ty of Arizona.\nNancy Willems\, Site Quality Leader – Medtronic Tempe Ca
 mpus\nNancy has the overall responsibility for the Tempe Campus quality sy
 stem and organization as the Quality Site Leader/Management Representative
 \, delivering the highest possible quality and reliability for our custome
 rs in compliance with all applicable ISO and FDA standards.\n\n&nbsp\;
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20190915T173000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR